Article Link: FDA Approves Genentech’s Gazyva for Previously Untreated Advanced Follicular Lymphoma Source: FDA New Drug Ap...
Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
Article Link: Noden Pharma Announces FDA Approval of Tekturna (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Year...
FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII
Article Link: FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII Source: FDA New Drug Approvals
FDA Approves Fasenra (benralizumab) for Severe Eosinophilic Asthma
Article Link: FDA Approves Fasenra (benralizumab) for Severe Eosinophilic Asthma Source: FDA New Drug Approvals
Allergan Receives FDA Approval for Vraylar (cariprazine) in the Maintenance Treatment of Schizophrenia
Article Link: Allergan Receives FDA Approval for Vraylar (cariprazine) in the Maintenance Treatment of Schizophrenia Source...
FDA Approves Abilify MyCite (aripiprazole) Pill with Sensor to Digitally Track if Patients Have Ingested Their Medication
Article Link: FDA Approves Abilify MyCite (aripiprazole) Pill with Sensor to Digitally Track if Patients Have Ingested Their Medication &...
FDA Expands Approval of Sprycel (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase
Article Link: FDA Expands Approval of Sprycel (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leuke...
FDA Approves Cinvanti (aprepitant) Injectable Emulsion for the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting (CINV)
Article Link: FDA Approves Cinvanti (aprepitant) Injectable Emulsion for the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting ...
Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults
Article Link: Dynavax Announces FDA Approval of Heplisav-B for Prevention of Hepatitis B in Adults Source: FDA New Drug App...
FDA Approves Prevymis (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplant Patients
Article Link: FDA Approves Prevymis (letermovir) for Prevention of Cytomegalovirus (CMV) Infection and Disease in Adult Allogeneic Stem Cell Transplan...
